The Natural History of Community-Associated Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections and an Evaluation of Decolonization Strategies.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 14 Jan 2020

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Chlorhexidine (Primary) ; Mupirocin (Primary) ; Sodium hypochlorite (Primary)
Indications Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
Focus Therapeutic Use
Acronyms StLStaRS

03 May 2011 Results presented at the 2011 Annual Meeting of the Pediatric Academic Societies.
04 Apr 2011 Actual end date changed from Nov 2009 to Dec 2010 as reported by ClinicalTrials.gov.
19 Jul 2010 Actual end date (November 2009) added as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com